NCT01647763

Brief Summary

Background: Hemorrhoids of grade 3 and 4 can be treated either by conventional, rather invasive procedures, like Milligan-Morgan or Ferguson or by modern, less invasive procedures with less postoperative pain. Doppler guided hemorrhoidal artery ligation and stapled hemorrhoidopexy are examples for such modern procedures. Hemorrhoidal artery ligation causes less post operative pain than stapled hemorrhoidopexy, however the former has a higher recurrence rate. Combining hemorrhoidal artery ligation with rectoanal repair should reduce the recurrence rate without increasing the post operative pain. Hypothesis and aim: The study tries to prove the assumption that combined hemorrhoidal artery ligation and rectoanal repair cause less pain and have less post operative complications than stapled hemorrhoidopexy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 18, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 24, 2012

Completed
10.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

11.4 years

First QC Date

July 18, 2012

Last Update Submit

August 7, 2023

Conditions

Keywords

Hemorrhoids

Outcome Measures

Primary Outcomes (1)

  • Pain POD1

    Visual analogue scale (VAS). Additionally recording of the pain medication used.

    between 6:00 am and 8:00 am the day after surgery

Secondary Outcomes (9)

  • Pain after 8h

    8 hours after surgery

  • Pain 30d

    30 days after surgery

  • Pain 1y

    1 year after surgery

  • Pain 2y

    2 years after surgery

  • post operative surgical complications

    within 30 post operative days

  • +4 more secondary outcomes

Study Arms (2)

HAL/RAR

EXPERIMENTAL

hemorrhoidal artery ligation with rectoanal repair

Procedure: Hemorrhoidal artery ligation with rectoanal repair

Stapled hemorrhoidopexy

ACTIVE COMPARATOR

procedure for prolapse and hemorrhoids (PPH) Resection using a circular stapler

Procedure: Stapled hemorrhoidopexy

Interventions

Hemorrhoidal arteries will be detected using an ultrasound Doppler probe. The arteries will be sutured with at least 4 Z-sutures. In the area with the 3 largest knots a purse string suture will be placed.

Also known as: HAL (hemorrhoidal artery ligation), RAR (rectoanal repair)
HAL/RAR

A purse string suture will be placed just below the hemorrhoidal cushion. Fixing the suture around the shaft of a circular PPH 03 stapler (Ethicon Endo-Surgery). Hemorrhoids will be removed by firing the stapler. Sufficiency of the stapler line will be examined through a proctoscope. Eventual sources of bleeding will be sutured.

Also known as: Longo procedure
Stapled hemorrhoidopexy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • hemorrhoids grade 3
  • no active anti-coagulation treatment
  • no hemorrhoidal recurrence
  • no previous surgery on rectum or anus
  • no previous local radiotherapy
  • no mental incapacities, good study compliance can be expected
  • no severe incontinence (Wexner score \> 12)
  • no severe comorbidities
  • no inflammatory anal diseases (abscesses, fistulas)
  • informed consent

You may not qualify if:

  • patient wish
  • inoperability with the assigned intervention, switching to other treatment method

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kantonsspital Rorschach

_Rorschach, 9400, Switzerland

Location

Kantonsspital St. Gallen

Sankt Gallen, 9007, Switzerland

Location

Related Links

MeSH Terms

Conditions

Hemorrhoids

Interventions

Retinoic Acid Receptor alpha

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Receptors, Retinoic AcidReceptors, Cytoplasmic and NuclearProteinsAmino Acids, Peptides, and ProteinsTranscription Factors

Study Officials

  • Lukas Marti, MD

    Cantonal Hospital St. Gallen, Department of Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Leitender Arzt (attending surgeon)

Study Record Dates

First Submitted

July 18, 2012

First Posted

July 24, 2012

Study Start

July 1, 2011

Primary Completion

December 1, 2022

Study Completion

December 1, 2024

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations